Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Infectious Diseases
Volume 2014 (2014), Article ID 234545, 4 pages
http://dx.doi.org/10.1155/2014/234545
Case Report

Cotreatment of Congenital Measles with Vitamin A and Intravenous Immunoglobulin

1Hacettepe University Medical Faculty, Pediatric Infectious Diseases Unit, Sıhhıye, 06100 Ankara, Turkey
2Department of Neonatology, Hacettepe University Faculty of Medicine, Ankara, Turkey
3Turkey Public Health Agency, Virology Reference and Research Laboratory, Ankara, Turkey

Received 10 September 2014; Revised 14 November 2014; Accepted 20 November 2014; Published 7 December 2014

Academic Editor: Daniela M. Cirillo

Copyright © 2014 Yasemin Ozsurekci et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. E. Chiba, M. Saito, N. Suzuki, Y. Honda, and N. Yaegashi, “Measles infection in pregnancy,” Journal of Infection, vol. 47, no. 1, pp. 40–44, 2003. View at Publisher · View at Google Scholar · View at Scopus
  2. M. E. Ali and H. M. Albar, “Measles in pregnancy: maternal morbidity and perinatal outcome,” International Journal of Gynecology & Obstetrics, vol. 59, no. 2, pp. 109–113, 1997. View at Publisher · View at Google Scholar · View at Scopus
  3. O. Anselem, V. Tsatsaris, E. Lopez et al., “Measles and pregnancy,” Presse Medicale, vol. 40, no. 11, pp. 1001–1007, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. G. D. Hussey and M. Klein, “A randomized, controlled trial of vitamin A in children with severe measles,” The New England Journal of Medicine, vol. 323, no. 3, pp. 160–164, 1990. View at Publisher · View at Google Scholar · View at Scopus
  5. World Health Organization, “Measles vaccines: WHO position paper,” Weekly Epidemiological Record, vol. 84, no. 35, pp. 349–360, 2009. View at Google Scholar
  6. E. Leuridan, N. Hens, V. Hutse, M. Ieven, M. Aerts, and P. Van Damme, “Early waning of maternal measles antibodies in era of measles elimination: longitudinal study,” The British Medical Journal, vol. 340, p. c1626, 2010. View at Google Scholar
  7. M. Muscat, H. Bang, J. Wohlfahrt, S. Glismann, and K. Mølbak, “Measles in Europe: an epidemiological assessment,” The Lancet, vol. 373, no. 9661, pp. 383–389, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. R. L. Atmar, J. A. Englund, and H. Hammill, “Complications of measles during pregnancy,” Clinical Infectious Diseases, vol. 14, no. 1, pp. 217–226, 1992. View at Publisher · View at Google Scholar · View at Scopus
  9. R. M. Zinkernagel, “Advances in immunology: maternal antibodies, childhood infections, and autoimmune diseases,” The New England Journal of Medicine, vol. 345, no. 18, pp. 1331–1335, 2001. View at Publisher · View at Google Scholar · View at Scopus
  10. E. Leuridan and P. Van Damme, “Passive transmission and persistence of naturally acquired or vaccine-induced maternal antibodies against measles in newborns,” Vaccine, vol. 25, no. 34, pp. 6296–6304, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. E. Leuridan, M. Sabbe, and P. van Damme, “Measles outbreak in Europe: susceptibility of infants too young to be immunized,” Vaccine, vol. 30, no. 41, pp. 5905–5913, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Scott, P. Cumberland, C. E. Shulman et al., “Neonatal measles immunity in rural Kenya: the influence of HIV and placental malaria infections on placental transfer of antibodies and levels of antibody in maternal and cord serum samples,” The Journal of Infectious Diseases, vol. 191, no. 11, pp. 1854–1860, 2005. View at Publisher · View at Google Scholar · View at Scopus